HLA-B27-FITC/HLA-B7-PE Antibody Cocktail, 50 Tests, CE
Product No:A07739
This mixture permits the characterization of HLA-B27 specificity in the HLA class I allotype in patients suffering from inflammatory disorders affecting the sacroiliac and intervertebral joints.
This finding aids in the diagnosis of ankylosing spondylitis 90% of sufferers of which express the HLA-B27 antigen, versus 7% in the normal population.The HLA-ABC-m3 monoclonal antibody recognizes the HLA-B27 antigen. It crosses with the HLA-B7 antigen and can also become fixed, but in a less refined manner, to the other antigens of CREG HLA-B7. The BB7.1 monoclonal antibody recognizes the HLA-B7 antigen.
Especificaciones
Target Species | Human |
Specificity | HLA-B27, HLA-B7 |
Fluorochrome | FITC, PE |
Regulatory Status | CE |
Size | 50 Tests |
Format | Liquid |
Flow Product Line | IOTest |
Clone | HLA-ABC-m3 / BB7.1 |